Legal & General Group PLC Acadia Pharmaceuticals Inc Transaction History

Legal & General Group PLC

$423 Billion
Q1 2024

A detailed history of Legal & General Group PLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Legal & General Group PLC holds 121,546 shares of ACAD stock, worth $1.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

121,546

Previous 112,345 8.19%

Holding current value

$1.93 Million

Previous $2.08 Million 8.18%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jul 01, 2024	BUY	$17.79 - $30.86 $163,685 - $283,942	9,201 Added 8.19%	121,546 $2.25 Million
Q1 2024 May 14, 2024	SELL	$17.79 - $30.86 $62,318 - $108,102	-3,503 Reduced 3.02%	112,345 $2.08 Million
Q4 2023 Feb 15, 2024	BUY	$20.78 - $31.77 $7,356 - $11,246	354 Added 0.31%	115,848 $3.63 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $11,962 - $19,211	574 Added 0.5%	115,494 $2.41 Million
Q2 2023 Aug 14, 2023	SELL	$17.8 - $25.65 $39,373 - $56,737	-2,212 Reduced 1.89%	114,920 $2.75 Million

Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $101,102 - $129,599	6,195 Added 5.58%	117,132 $2.2 Million
Q4 2022 Feb 14, 2023	SELL	$14.2 - $18.63 $10,153 - $13,320	-715 Reduced 0.64%	110,937 $1.77 Million
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $78,282 - $101,361	-5,548 Reduced 4.73%	111,652 $1.83 Million
Q2 2022 Aug 22, 2022	SELL	$13.01 - $27.22 $32,511 - $68,022	-2,499 Reduced 2.09%	117,200 $1.65 Million
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $336,819 - $442,337	16,085 Added 15.52%	119,699 $2.9 Million
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $61,182 - $98,715	-3,644 Reduced 3.4%	103,614 $2.42 Million
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $388,361 - $609,614	24,611 Added 29.78%	107,258 $1.78 Million
Q2 2021 Aug 12, 2021	SELL	$19.4 - $27.42 $959,388 - $1.36 Million	-49,453 Reduced 37.44%	82,647 $2.02 Million
Q1 2021 May 17, 2021	SELL	$25.02 - $54.99 $35,253 - $77,480	-1,409 Reduced 1.06%	132,100 $3.41 Million
Q4 2020 Feb 12, 2021	SELL	$41.04 - $56.79 $541,563 - $749,400	-13,196 Reduced 8.99%	133,509 $7.14 Million
Q3 2020 Nov 13, 2020	SELL	$36.42 - $57.0 $14,130 - $22,116	-388 Reduced 0.26%	146,705 $6.05 Million
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $2.71 Million - $3.64 Million	68,995 Added 88.34%	147,093 $7.13 Million
Q1 2020 May 14, 2020	BUY	$31.65 - $46.87 $184,203 - $272,783	5,820 Added 8.05%	78,098 $3.3 Million
Q4 2019 Feb 13, 2020	BUY	$36.21 - $51.4 $445,201 - $631,963	12,295 Added 20.5%	72,278 $3.09 Million
Q3 2019 Nov 13, 2019	BUY	$22.22 - $44.01 $144,696 - $286,593	6,512 Added 12.18%	59,983 $2.16 Million
Q2 2019 Aug 14, 2019	SELL	$23.32 - $28.12 $16,324 - $19,684	-700 Reduced 1.29%	53,471 $1.43 Million
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $194,428 - $329,217	12,024 Added 28.53%	54,171 $1.46 Million
Q4 2018 Feb 15, 2019	BUY	$14.32 - $22.92 $112,841 - $180,609	7,880 Added 23.0%	42,147 $681,000
Q2 2018 Aug 10, 2018	SELL	$15.07 - $22.34 $213,345 - $316,267	-14,157 Reduced 29.24%	34,267 $523,000
Q1 2018 May 17, 2018	SELL	$22.47 - $32.33 $43,030 - $61,911	-1,915 Reduced 3.8%	48,424 $1.09 Million
Q4 2017 Feb 13, 2018	BUY	$26.84 - $39.14 $1.35 Million - $1.97 Million	50,339	50,339 $1.52 Million

Others Institutions Holding ACAD

# of Institutions

299

Shares Held

158M

Call Options Held

1.88M

Put Options Held

688K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.56B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Acadia Pharmaceuticals Inc Transaction History